NEW
YORK, Oct. 23, 2024 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by Lumos
Pharma, Inc. (NASDAQ: LUMO) and its board of directors concerning
the proposed acquisition of the company by Double Point Ventures
LLC. Stockholders will receive $4.25
and one contingent value right for each share of Lumos Pharma stock
that they hold. The transaction is expected to close by the end of
2024.
If you are a stockholder of Lumos Pharma, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/lumo/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-lumos-pharma-inc-302284927.html
SOURCE Rowley Law PLLC